AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
Clinical trial NCT03147040 · TERMINATED
Trial details
- NCT number
- NCT03147040
- Sponsor
- The Netherlands Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2022-05-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.